THE K-CONNECT PLATFORM
The K-CONNECT Platform creates as a collaborative initiative that brings together leading oncologists and researchers from across the region. The platform serves as a bridge between cutting-edge technology and expert practitioners, aiming to unlock the potential of ctDNA-MRD for precision and personalized oncology.
Gene Solutions recently published a report in JCO Oncology Advances on a multi-center, real-world study of ctDNA utilization in Southeast Asia to predict recurrence in solid tumors (DOI: 10.1200/OA-24-00084).
In further discussions with multiple oncology experts across different countries who are using ctDNA-MRD in their practice, we have identified a gap between available technology and real-world utilization.
To address this, we are forming a platform named K-CONNECT, which brings together leading oncologists and researchers from across the region. This platform will serve as a bridge between cutting-edge technology and expert practitioners, aiming to unlock the potential of ctDNA-MRD and CGP for precision and personalized oncology.
K-CONNECT 2025 INITIAL ACTIVITIES:
SCIENTIFIC UPDATES AND KNOWLEDGE SHARING
K-CONNECT 2025 Meeting
An academic event in Danang, Vietnam, to foster collaboration and knowledge sharing among oncologists in the Asia-Pacific region.
Online Resources
The K-CONNECT Online Hub provides resources for oncologists, researchers, and healthcare professionals across the region, including MRD, genomic profiling applications, and case studies.
Webinars
A series of webinars for knowledge sharing, covering the latest advancements in cancer treatment and emerging technologies in precision medicine.
COLLABORATION AND CLINICAL TRIALS
Experiencing MRD
A series of collaborations to improve healthcare access, advance medical research, and strengthen the industry's commitment to social good.
Clinical Trials Support
Tailored support for applicants, including:
- Genomic profiling assays
- ctDNA monitoring assays
- Novel biomarker findings
